Postmenopausal Hormone-Replacement Therapy
- 5 July 2001
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (1) , 34-40
- https://doi.org/10.1056/nejm200107053450106
Abstract
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.Patient 1 is a 52-year-old woman at average risk for breast cancer and osteoporosis who is having menopause-related hot flashes and disturbed sleep. Patient 2 is a 58-year-old woman with osteopenia whose mother had breast cancer. Patient 3 is a 65-year-old woman with a history of coronary revascularization and documented osteoporosis. Each wants to know whether hormone-replacement therapy is right for her.The Clinical ProblemOverviewOne of the most complex and difficult health care decisions that women face is whether to use postmenopausal hormone-replacement therapy. The average woman in the United States lives nearly 30 years after menopause, . . .Keywords
This publication has 28 references indexed in Scilit:
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- A Decision Tree for the Use of Estrogen Replacement Therapy or Hormone Replacement Therapy in Postmenopausal WomenMenopause, 2000
- DiscussionAmerican Journal of Preventive Medicine, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONSAnnual Review of Public Health, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Hormone replacement therapy and endometrial cancer risk: A meta-analysisObstetrics & Gynecology, 1995
- Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI TrialJAMA, 1995
- Postmenopausal hormone therapy and atherosclerotic diseaseAmerican Heart Journal, 1994
- Maximizing the Benefit of Estrogen Therapy for Prevention of OsteoporosisMenopause, 1994